Trial Profile
Effect of Guanfacine Extended-Release on Attention Deficit Hyperactivity Disorder (ADHD)-Associated Insomnia.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 04 Aug 2016
Price :
$35
*
At a glance
- Drugs Guanfacine (Primary)
- Indications Attention-deficit hyperactivity disorder; Insomnia
- Focus Therapeutic Use
- Sponsors Shire
- 30 Mar 2012 Actual patient number (32) added as reported by ClinicalTrials.gov.
- 30 Mar 2012 Actual patient number (32) added as reported by ClinicalTrials.gov.
- 30 Mar 2012 Planned end date changed from 1 Nov 2011 to 1 Feb 2012 as reported by ClinicalTrials.gov.